US FDA accepts for review Dr Reddy’s BLA for proposed interchangeable biosimilar, abatacept: Our Bureau, Bengaluru Monday, February 23, 2026, 12:20 Hrs [IST] Dr Reddy’s Labora ...

USFDA accepts for review Dr Reddy's biologics license application for Orencia biosimilar DRL_AB Swati Bharadwaj Hyderabad: Dr Reddy’s Laboratories Ltd.

With the ninth-generation Hilux already unveiled globally in November 2025, Fortuner’s arrival in new-gen form was inevitable ...

The Railsplitters got a stiff test from the visiting Bears, who turned in their highest-scoring output of the season. However ...

TRENTON — A couple of Downriver League girls basketball teams continued their respective late-season pushes when Wyandotte Roosevelt and Trenton held their second head-to-head meeting of the season on ...

Nomura India said DRL's acquisitions over the past five years may contribute around one-quarter of the company’s revenues in ...

Dr. Reddy’s Laboratories (RDY) stock is in focus as the FDA agrees to review its biosimilar targeting Bristol Myers' (BMY) ...

Dr Reddy's Laboratories is strategically shifting focus towards biosimilars and innovation. The company is increasing investment in biosimilars, anticipating significant growth within five years.

MG Motor India's new Majestor SUV has been revealed and it gets a dominating road presence and a cabin fit for a ...

Aftermarket lighting specialist Morimoto has introduced new LED headlights for the C6 Corvette, serving up an overview and ...

Mechanically, there are no changes; it continues to get two engine options - a 1.0-litre, 3-cylinder, turbo petrol with 115 hp and 175 nm torque. Another engine is a 1.5-litre, 4-cylinder, turbo ...

The US Food and Drug Administration (USFDA) has greenlit Dr Reddy's Biologics License Application for a proposed biosimilar to Orencia (abatacept).